What turns CREB on? And off? And why does it matter?

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• The transcription factor cyclic AMP response-binding protein (CREB) is implicated in various cellular processes.
• Dysregulation of CREB is increasingly recognized in the development and progression of cancer.
• CREB's role in patient survival and response to cancer therapy is a significant area of research.

Purpose of the Study:

• To review the expression and activation patterns of CREB in both normal physiological states and diverse tumor types.
• To elucidate the regulatory mechanisms governing CREB activity by various signaling pathways and inhibitory molecules.
• To summarize the clinical significance of CREB as a biomarker and therapeutic target in oncology.

Main Methods:

• Literature review and synthesis of existing research on CREB in cancer.
• Analysis of studies detailing CREB expression, activation, and regulation.
• Compilation of data on CREB's clinical relevance, including prognostic and predictive value.

Main Results:

• CREB exhibits altered expression and function in various cancers, correlating with patient prognosis.
• Multiple stimuli and inhibitors modulate CREB activity through diverse signaling pathways.
• CREB serves as a potential prognostic marker and therapeutic target in cancer treatment.

Conclusions:

• CREB is a critical factor in cancer pathogenesis and patient outcomes.
• Understanding CREB regulation provides insights into potential therapeutic strategies.
• Targeting CREB may offer new avenues for cancer therapy and improved patient management.